Lucira Health, Inc.

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Q: Jun 30 2021

Q: Mar 31 2021

FY: Dec 31 2020

1.03,3.03,5.02,8.01,9.01

8.01,9.01

1.01,2.01,8.01,9.01

1.01,9.01

8.01

8.01,9.01

3.01,7.01,9.01

1.03,5.02,7.01,9.01

5.02,8.01

5.02

1.02

3.01

5.02

2.02,9.01

8.01

5.02

5.02

2.02,9.01

5.07

2.02,9.01

Certification of termination of registration of a class of securities (Section 12(g))

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notification of removal from listing and/or registration on a national securities exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Amended Initial Registration Statement

Registration of Securities on Exchange

Registration (IPO) statement under Securities Act of 1933

06b

06b

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Engelson Erik T.

Allen Anthony Joseph

Collins Kevin Walter

Narido Richard Clavano

Kashmolah Ghazi

none

Allen Anthony Joseph

EPQ LLC, LFLU PS

Kashmolah Ghazi

Kashmolah Ghazi

Allen Anthony Joseph

Narido Richard Clavano

Collins Kevin Walter

Narido Richard Clavano

Kashmolah Ghazi

Allen Anthony Joseph

George Dan

Engelson Erik T.

Mitra Debkishore

Collins Kevin Walter

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)